The Emory MSTP prepares highly gifted and motivated students to pursue careers as physician-scientists and leaders in biomedical research. The seven to eight year training process leads to both M.D. and Ph.D. degrees. The M.D./Ph.D. Executive Committee, comprised of institutional leadership representing the many academic units involved in training, is responsible for oversight of the program. Selection of applicants is highly competitive and is made by the M.D./Ph.D. Admissions Committee after extensive evaluation of prior scholarship and research experience, review of letters of recommendation, and in-depth interviews to assess motivation and determine the potential for success as physician-scientists. The program allows for flexibility in program affiliation, as well as the sequence and duration of clinical or research training, but most trainees pursue the following course of study. Students engage in laboratory research in the summer prior to the first year of Medical School. During the summer between the first and second year of Medical School, they carry out research in their proposed area of study. Following the second year of Medical School, each trainee begins his/her graduate training in advanced study. Trainees pursue dissertation research in a variety of outstanding graduate programs, including any of eight interdisciplinary training programs in the Emory Graduate School Division of Biological and Biomedical Sciences, in the Biomedical Engineering Program offered by the unique combined Department of Biomedical Engineering of Georgia Tech/Emory, in new programs in Biostatistics and Epidemiology offered by the Emory Rollins School of Public Health, or in one of several other scientific disciplines offered by the Graduate School of Arts and Sciences. Each trainee completes at least 14 months of clinical training after defending his/her thesis. The dramatic expansion of the research and clinical infrastructure at Emory and increased institutional support have facilitated the successful growth and development of the MSTP.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM008169-20
Application #
7099438
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Shapiro, Bert I
Project Start
1987-07-01
Project End
2007-06-30
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
20
Fiscal Year
2006
Total Cost
$819,104
Indirect Cost
Name
Emory University
Department
Neurology
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Inan, Omer T; Whittingslow, Daniel C; Teague, Caitlin N et al. (2018) Wearable knee health system employing novel physiological biomarkers. J Appl Physiol (1985) 124:537-547
Dahotre, Shreyas N; Chang, Yun Min; Wieland, Andreas et al. (2018) Individually addressable and dynamic DNA gates for multiplexed cell sorting. Proc Natl Acad Sci U S A 115:4357-4362
Chiang, Bryce; Jung, Jae Hwan; Prausnitz, Mark R (2018) The suprachoroidal space as a route of administration to the posterior segment of the eye. Adv Drug Deliv Rev 126:58-66
Kudelka, Matthew R; Nairn, Alison V; Sardar, Mohammed Y et al. (2018) Isotopic labeling with cellular O-glycome reporter/amplification (ICORA) for comparative O-glycomics of cultured cells. Glycobiology 28:214-222
Jang, Yeongseon; Choi, Won Tae; Johnson, Christopher T et al. (2018) Inhibition of Bacterial Adhesion on Nanotextured Stainless Steel 316L by Electrochemical Etching. ACS Biomater Sci Eng 4:90-97
Rowson, Sydney A; Foster, Stephanie L; Weinshenker, David et al. (2018) Locomotor sensitization to cocaine in adolescent and adult female Wistar rats. Behav Brain Res 349:158-162
Chambers, Dwight M; Moretti, Leandro; Zhang, Jennifer J et al. (2018) LEM domain-containing protein 3 antagonizes TGF?-SMAD2/3 signaling in a stiffness-dependent manner in both the nucleus and cytosol. J Biol Chem 293:15867-15886
Woods, Emily C; Edwards, Adrianne N; Childress, Kevin O et al. (2018) The C. difficile clnRAB operon initiates adaptations to the host environment in response to LL-37. PLoS Pathog 14:e1007153
Manvich, Daniel F; Webster, Kevin A; Foster, Stephanie L et al. (2018) The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice. Sci Rep 8:3840
Chou, Ching-Chieh; Zhang, Yi; Umoh, Mfon E et al. (2018) TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat Neurosci 21:228-239

Showing the most recent 10 out of 466 publications